Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 17/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.66 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | SYK | P43405 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5688564 | 1.00 | CYP17A1 (0.66) | CYP17A1CYP3A4ADAMTS4CYP11B1CYP11B2 | |
| SCHEMBL29478298 | 1.00 | CYP17A1 (0.66) | CYP17A1CYP3A4ADAMTS4CYP11B1CYP11B2 | |
| SCHEMBL5688287 | 0.93 | CYP17A1 (0.56) | CYP17A1CYP3A4ADAMTS4SYK | |
| SCHEMBL5688374 | 0.90 | CYP17A1 (0.63) | CYP17A1CYP3A4ADAMTS4 | |
| SCHEMBL22284856 | 0.90 | CYP17A1 (0.67) | CYP17A1CYP3A4 | |
| SCHEMBL7563598 | 0.90 | CYP17A1 (0.53) | CYP17A1CYP3A4 | |
| SCHEMBL5688634 | 0.89 | CYP17A1 (0.52) | CYP17A1CYP3A4 | |
| SCHEMBL5690716 | 0.88 | CYP17A1 (0.51) | CYP17A1CYP3A4SYK | |
| SCHEMBL5690790 | 0.87 | CYP17A1 (0.64) | CYP17A1CYP3A4CYP11B1CYP11B2SYK | |
| SCHEMBL5688811 | 0.86 | CYP17A1 (0.55) | CYP17A1CYP3A4ADAMTS4CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1227086-A1 | 1-SUBSTITUTED PHENYL-1-(1H-IMIDAZOL-4-YL) ALCOHOLS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-07-31 | — | — | EP | disclosed |